Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG) positivity has been reported in some people with multiple sclerosis (pwMS), posing a diagnostic challenge. However, most studies have been conducted in predominantly Caucasian populations. We aimed to determine the frequency of MOG-IgG in a large, predominantly Asian MS cohort using a validated MOG-IgG assay.
Methods: Between 2005 and 2024, consecutive people diagnosed with MS according to the 2017 McDonald criteria were enrolled from the National Cancer Center registry. Serum samples from 405 pwMS were tested for MOG-IgG using an in-house live cell-based assay at a 1:20 dilution. Borderline or positive samples were retested at a 1:100 dilution by investigators blinded to clinical data.
Results: Among the 405 pwMS (98% Asian, 66% female, median age at onset 28 years), the overall proportion of MOG-IgG positive or borderline results was 1.5% (n = 6). Clear MOG-IgG positivity was extremely rare (n = 1, 0.3%), though positive or borderline results at low titer only were observed in 1.2% (n = 5) of pwMS.
Conclusions: True MOG-IgG positivity in MS is uncommon across populations, but low titer positive or borderline results may complicate diagnosis. Comprehensive clinical assessment remains essential, and repeat testing at higher dilutions can be helpful to avoid misdiagnosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12412035 | PMC |
| http://dx.doi.org/10.1111/ene.70356 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
MOG-IgG Frequency in Multiple Sclerosis: Diagnostic Challenges With Low-Titer Results.
Eur J Neurol
September 2025
Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.
Background: Myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG) positivity has been reported in some people with multiple sclerosis (pwMS), posing a diagnostic challenge. However, most studies have been conducted in predominantly Caucasian populations. We aimed to determine the frequency of MOG-IgG in a large, predominantly Asian MS cohort using a validated MOG-IgG assay.
View Article and Find Full Text PDFRetinal ganglion cell function in AQP4+ and MOG+ optic neuritis.
Mult Scler Relat Disord
August 2025
Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Aim: To compare retinal ganglion cell function between optic neuritis (ON) cases positive for anti-aquaporin-4 antibody (AQP4+) and myelin oligodendrocyte glycoprotein (MOG+).
Methods: Patients tested positive for AQP4 or MOG and history of ON at least six months prior to enrollment were included. An ophthalmological examination, visual acuity test (BCVA), visual field test (mean deviation, MD) and spectral-domain optical coherence tomography (OCT) were performed.
Repeated MRI-negative demyelinating attacks linked to MOG-IgG antibodies and silent lesions - Case series and literature review.
Clin Neurol Neurosurg
October 2025
Department of Neurology and Laboratory of Neuroimmunology, and the Agnes-Ginges Center for Neurogenetics, Hadassah, Medical Center, Ein-Kerem, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address:
Background: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) is an inflammatory demyelinating disorder of the central nervous system. While spinal MRI in MOGAD typically reveals longitudinally extensive transverse myelitis lesions, often involving the conus, rare cases of clinical myelitis without radiological abnormalities have been reported. This study aimed to characterize such MRI-negative presentations in MOGAD and compare them with previously published cases.
View Article and Find Full Text PDFStructural and functional biomarkers of visual dysfunction in MOG antibody-positive optic neuritis: a scoping review.
J Neuroimmunol
August 2025
Translational Neuroimmunology Group, Kids Neuroscience Centre and ANZAC Research Institute, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Department of Neurology, Concord Clinical School, Concord Hospital, Sydney, Australia. Electronic address: sudar
Introduction: Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) commonly manifests as optic neuritis (ON) in association with serum MOG immunoglobulin G (MOG-IgG). This review will evaluate the literature on visual dysfunction in MOG-IgG ON, with a focus on ophthalmic structural biomarkers and ancillary outcome measures.
Methods: PubMed was systematically searched using the terms "optic neuritis", "visual outcomes" and "myelin-oligodendrocyte glycoprotein" between 2007 to January 2025.
Clinical, Radiologic, and Optical Coherence Tomographic Features of Pediatric Acute Disseminated Encephalomyelitis: Comparison of Myelin Oligodendrocyte Glycoprotein Antibody-Positive and -Negative Cases.
Pediatr Neurol
October 2025
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas.
Background: Acute disseminated encephalomyelitis (ADEM) typically presents as a monophasic demyelinating disorder associated with multifocal neurological symptoms and encephalopathy in children. Myelin oligodendrocyte glycoprotein antibody (MOG-IgG) is detected in a subset of patients and may be linked to recurrence risk. This study evaluated the clinical, radiologic, and optic coherence tomographic (OCT) features of children with ADEM based on MOG-IgG serostatus.
View Article and Find Full Text PDF